Showing results (791-800 of 860) with videos related to

Sort By:
Pageof 86
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
Journal of Medicinal Chemistry|January 18, 2019
Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C VirusSeema Mengshetti, Longhu Zhou, Ozkan Sari, et al.
Psychological Medicine|November 4, 2015
Polygenic interactions with environmental adversity in the aetiology of major depressive disorderN Mullins, R A Power, H L Fisher, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 24, 2018
Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studiesChiara Fabbri, Katherine E Tansey, Roy H Perlis, et al.
The Pharmacogenomics Journal|January 22, 2014
Copy number variants and therapeutic response to antidepressant medication in major depressive disorderK E Tansey, J J H Rucker, D H Kavanagh, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 29, 2025
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, et al.
Journal of the National Cancer Institute|August 20, 2021
Germline SUCLG2 Variants in Patients With Pheochromocytoma and ParagangliomaKaterina Hadrava Vanova, Ying Pang, Linda Krobova, et al.
BMJ Open|August 8, 2018
Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health dataLinda Kwakkenbos, Mahrukh Imran, Kimberly A McCord, et al.
JAMA Psychiatry|February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in DepressionAndre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Pageof 86